Guggenheim Securities adjusted its price target for Immunovant shares, listed on (NASDAQ:IMVT), to $44.00, a decrease from the previous $46.00, while sustaining a Buy rating on the stock. Currently ...
H.C. Wainwright reaffirmed their Buy rating on Immunovant (NASDAQ:IMVT) shares with a price target of $51.00, aligning with the broader Wall Street sentiment. According to InvestingPro data, analyst ...
MUMBAI: The tally of Guillain Barre Syndrome (GBS) cases in Maharashtra has reached 189, while the first GBS-suspected patient from Andheri-East was detect ...
Michael Klim's new love with founder of Almost Real and Snaaps, Michelle Owen, is about moments, memories and the magic of shared adventures.
Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...
Severe cases of Guillain-Barr syndrome (GBS) can result in near-total paralysis. GBS is more common in adults and males, ...
The tally of suspected Guillain-Barré syndrome (GBS) cases in the Pune region has reached 180, with the detection of seven ...
Barré Syndrome (GBS), a rare nerve disorder, in a 64-year-old woman. The patient, who resides in Andheri east, was ...
Mumbai reported its first case of Guillain-Barre Syndrome (GBS) on Friday after a 64-year-old woman was diagnosed with the rare nerve disorder, civic officials said. GBS is a rare condition in which a ...